Consilium Staffing Lifts Up Military Veterans With Postcard Drive
News provided by
Share this article
Share this article
DALLAS, May 25, 2021 /PRNewswire/ Consilium Staffing, a premier locum tenens healthcare staffing firm bringing doctors and advanced practitioners to facilities nationwide, announced that its employees have sent 108 handwritten postcards to the Oncology Department at the Fayetteville Veterans Affairs Medical Center (VAMC) to honor patients during Military Appreciation Month. Each postcard was filled with uplifting messages of love, hope, and gratitude with the intent to encourage and support veterans as they persevere through their cancer treatments. The postcard drive was led by Consilium Cares, the dedicated philanthropic initiative of Consilium Staffing.
/PRNewswire/ FBSciences, a global leader in the innovation and commercialization of sustainable biologicals for agriculture and food production, launches.
Medivir to present at the ABGSC Life Science Summit
News provided by
Share this article
STOCKHOLM, May 25, 2021 /PRNewswire/
Medivir AB (Nasdaq Stockholm: MVIR) announces that the company will present at the virtual meeting ABGSC Life Science Summit, today, May 25.
The company will be represented by
Magnus Christensen, interim CEO, and Fredrik Öberg, Chief Scientific Officer.
The presentation will be available after the seminar on Medivirs website; www.medivir.com.
For additional information, please contact
Magnus Christensen, interim CEO and CFO
Telephone: +46 8 5468 3100
Medivir in brief
Medivir develops innovative drugs with a focus on cancer where the unmet medical needs are high. The drug candidates are directed toward indication areas where available therapies are limited or missing and there are great opportunities to offer significant improvements to patients. Medivir is focusing on the development of MIV-818, a pro-drug designed to selectively treat li
Share this article
Share this article
NEW YORK, May 25, 2021 /PRNewswire/ The cancer therapeutics market is one of the largest segments of the biotechnology industry. According to the National Cancer Institute, roughly 1.8 million people were diagnosed with cancer in the United States in 2020 alone. However, the oncology and cancer drug market is expected to grow largely due to the surge in cancer research, the rise in the geriatric population worldwide, as well as the increase in collaboration between pharmaceutical companies. Moreover, the high market growth potential in developing nations, a rise in the number of pipeline products, and an upsurge in demand for personalized medicines are expected to create new opportunities for market players. And, according to data published by Market Industry Reports, the cancer therapeutics market was estimated to be valued at over USD 140 Billion in 2019 and is anticipated to grow at a CAGR of ~7.7% from 2019 to 2030. Sunshine Biopharma Inc
Share this article
Share this article
- OptraSCAN s Intelligent Tool CytoSiA – To Advance Cytology Screening Through Unmatched Image Quality And Artificial Intelligence Based Image Analysis Solution
SAN JOSE, Calif. and PUNE, India, May 25, 2021 /PRNewswire/ OptraSCAN®, the leading On-Demand Digital Pathology solution provider, today announced its intelligent solution CytoSiA for rapid yet affordable scanning and analyzing of liquid-based cytology slides and pap-smears. It is a complete solution consisting of OptraSCAN s digital pathology scanner, storage, and powerful artificial intelligence (AI) algorithms to assist pathologists and cytotechnologists in screening and detection of cervical cancer, pre-cancerous lesions, atypical cells, and all other cytologic categories. Multiple hospitals and pathology laboratories globally have already installed